Akero Therapeutics Inc’s filing revealed that its Chief Scientific Officer Rolph Timothy unloaded Company’s shares for reported $0.62 million on Aug 05 ’25. In the deal valued at $49.30 per share,12,500 shares were sold. As a result of this transaction, Rolph Timothy now holds 167,124 shares worth roughly $8.07 million.
Then, Yale Catriona sold 10,000 shares, generating $529,467 in total proceeds. Upon selling the shares at $52.95, the Chief Development Officer now owns 91,488 shares.
Before that, Cheng Andrew sold 30,000 shares. Akero Therapeutics Inc shares valued at $1,534,895 were divested by the President and CEO at a price of $51.16 per share. As a result of the transaction, Cheng Andrew now holds 520,757 shares, worth roughly $25.14 million.
TD Cowen initiated its Akero Therapeutics Inc [AKRO] rating to a Buy in a research note published on August 04, 2025; the price target was $76. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in late January from “a Neutral” to “a Buy”. H.C. Wainwright also remained covering AKRO and reiterated its “Buy” recommendation on January 27, 2025. Citigroup started covering the stock on November 18, 2024. It rated AKRO as “a Buy”.
Price Performance Review of AKRO
On Monday, Akero Therapeutics Inc [NASDAQ:AKRO] saw its stock fall -4.32% to $48.28. Over the last five days, the stock has lost -0.70%. Akero Therapeutics Inc shares have risen nearly 103.89% since the year began. Nevertheless, the stocks have risen 73.54% over the past one year. While a 52-week high of $58.40 was reached on 01/27/25, a 52-week low of $21.34 was recorded on 01/14/25.
Levels Of Support And Resistance For AKRO Stock
The 24-hour chart illustrates a support level at 47.09, which if violated will result in even more drops to 45.89. On the upside, there is a resistance level at 49.76. A further resistance level may holdings at 51.23.
How much short interest is there in Akero Therapeutics Inc?
A steep rise in short interest was recorded in Akero Therapeutics Inc stocks on 2025-07-15, growing by 0.41 million shares to a total of 8.16 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 7.75 million shares. There was a rise of 5.06%, which implies that there is a positive sentiment for the stock.
